Markets:

Overview

News

Currencies

International

Treasuries

ALX Oncology Holdings Inc. - Common Stock (NQ:ALXO)

2.210 -0.195 (-8.11%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ALX Oncology Holdings Inc. - Common Stock

< Previous 1 2 3 4 Next >

S&P 500, Nasdaq Futures Waver As Focus Turns To JOLTS Data: Why These Analysts Say Expecting A Strong Q4 This Year Is 'Tricky' ↗

October 03, 2023

Index futures point to a modestly higher opening on Tuesday, while 10-year Treasury yields have surged to over 4.70%, adding to uncertainty about interest rates.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 02, 2023

Via Benzinga

Where ALX Oncology Holdings Stands With Analysts ↗

September 07, 2023

Via Benzinga

4 Analysts Have This to Say About ALX Oncology Holdings ↗

August 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 21, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About ALX Oncology Holdings ↗

May 12, 2023

Via Benzinga

Recap: ALX Oncology Holdings Q1 Earnings ↗

May 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 06, 2023

Via Benzinga

Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session ↗

July 06, 2023

Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 21, 2023

Via Benzinga

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 21, 2023

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

Via Benzinga

National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday ↗

January 13, 2023

U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday ↗

January 10, 2023

U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 10, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 10, 2023

Via Benzinga

AMC Preferred Equity Units, Accolade And Some Other Big Stocks Moving Higher On Friday ↗

December 23, 2022

U.S. stocks traded mixed, with the Dow Jones gaining over 50 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 11, 2022

Via Benzinga

ALX Oncology Shares Climb As Mid-Stage Triple Combination Colorectal Cancer Study Kicks-off ↗

August 11, 2022

ALX Oncology Holdings (NASDAQ: ALXO) has initiated a Phase 2 investigator-sponsored study of evorpacept in combination with Eli Lilly’s (NYSE: LLY) ERBITUX (cetuximab) and Merck’s (NASDAQ:

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 01, 2022

Via Benzinga

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial ↗

August 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

ALX Oncology Shares Gain As FDA Grants Fast Track Status To Head And Neck Cancer Candidate ↗

August 01, 2022

ALX Oncology Holdings (NASDAQ: ALXO) receives Fast Track designation from the U.S. Food and Drug Administration (FDA) for its lead asset Evorpacept in combination with KEYTRUDA (pembrolizumab) for the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 12, 2022

Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.

Via Benzinga

The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data ↗

June 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

ALX Oncology Shares Soar As FDA Grants Orphan Drug Status To Blood Cancer Candidate ↗

June 29, 2022

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALX Oncology Holdings’ (NASDAQ: ALXO) Evorpacept for the treatment of patients with acute myeloid leukemia (AML).

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 29, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 06, 2022

Monday's session saw 84 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 31, 2022

On Tuesday, 36 companies achieved new lows for the year.

Via Benzinga

ALX Oncology Holdings: Q4 Earnings Insights ↗

February 28, 2022

ALX Oncology Holdings (NASDAQ:ALXO) reported its Q4 earnings results on Monday, February 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement...

Via Benzinga

The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron ↗

January 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ALX Oncology Holdings Inc. - Common Stock (NQ:ALXO)

Headline News about ALX Oncology Holdings Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today